Agomelatine
Showing 1 - 25 of 33
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in
Not yet recruiting
- Polymorphism, Genetic
- +5 more
- (no location specified)
Nov 3, 2023
Depression, Acute Ischemic Stroke Trial (Agomelatine, Placebo Tablets)
Not yet recruiting
- Depression
- Acute Ischemic Stroke
- Agomelatine
- Placebo Tablets
- (no location specified)
Jul 26, 2022
Schizophrenia, Negative Symptoms in Schizophrenia Trial in Shanghai (Agomelatine)
Recruiting
- Schizophrenia
- Negative Symptoms in Schizophrenia
- Agomelatine
-
Shanghai, ChinaShanghai Mental Health Center
Dec 9, 2022
15 Different Antidepressants in Major Depressive Disorder
Completed
- Major Depressive Disorder
-
Copenhagen, DenmarkPsychiatric Center Copenhagen
Jul 18, 2023
MDD Trial in Changsha (Agomelatine, Placebos)
Unknown status
- MDD
- Agomelatine
- Placebos
-
Changsha, Hunan, ChinaMental Health Institute & Faculty of Psychiatry of The Second Xi
Oct 9, 2020
MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )
Completed
- Major Depressive Disorder
- Agomelatine
- +2 more
-
Phoenix, Arizona
- +46 more
Dec 15, 2020
MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)
Completed
- Major Depressive Disorder
- Agomelatine (AGO178C)
- Placebo
-
Birmingham, Alabama
- +47 more
Dec 15, 2020
MDD Trial in Puerto Rico, United States (agomelatine, )
Completed
- Major Depressive Disorder
- agomelatine
- placebo
-
Scottsdale, Arizona
- +43 more
Dec 15, 2020
MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)
Completed
- Major Depressive Disorder
- Agomelatine (AGO178C)
- Placebo
-
Birmingham, Alabama
- +44 more
Dec 16, 2020
Obsessive Compulsive Disorder Trial in Tel Hashomer (Agomelatine A, Placebo)
Completed
- Obsessive Compulsive Disorder
- Agomelatine A
- Placebo
-
Tel Hashomer, IsraelDepartment of Psychiatry Chaim Sheba Medical Center
Jan 2, 2020
MDD (MDD) Trial in United States (agomelatine, )
Completed
- Major Depressive Disorder (MDD)
- agomelatine
- placebo
-
Mesa, Arizona
- +50 more
Dec 15, 2020
MDD Trial in Kaohsiung (electroconvulsive therapy, agomelatine, Placebo)
Completed
- Major Depressive Disorder
- electroconvulsive therapy
- +2 more
-
Kaohsiung, TaiwanKaohsiung Municipal Kai-Syuan Psychiatric Hospital
Nov 27, 2019
MDD Trial in United States (agomelatine, )
Completed
- Major Depressive Disorder
- agomelatine
- placebo
-
Birmingham, Alabama
- +77 more
Dec 15, 2020
Depression After SARS-CoV-2 (TELESPHOR)
Recruiting
- Depression
- COVID-19
-
Moscow, Russian FederationFederal State Autonomous Educational Institution of Higher Educa
Oct 25, 2022
Parkinson Disease, Depression, Sleep Disorders Trial (Agomelatine or PIacebo)
Unknown status
- Parkinson Disease
- +3 more
- Agomelatine or PIacebo
- (no location specified)
Jun 5, 2019
Depressive Disorder, Treatment-Resistant Trial (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Withdrawn
- Depressive Disorder, Treatment-Resistant
- Esketamine 28 mg
- +10 more
- (no location specified)
Nov 22, 2019
Prediction of Adolescents With MDD Response to ECT Via MRI
Recruiting
- Major Depressive Disorder
- +2 more
- Modified Electroconvulsive Therapy
- Conventional pharmacotherapy
-
Chongqing, Province, ChinaThe First Affiliated Hospital of Chongqing Medical University
May 26, 2023
Depression in Old Age Trial in Saint-Avé, Rennes (Wheelchair)
Recruiting
- Depression in Old Age
- Wheelchair
-
Saint-Avé, Bretagne, France
- +1 more
Aug 5, 2022
Melatonin Decreases Eye Pressure in Normotensive Patients
Completed
- Depressive Disorder
- Agomelatine 25 MG Oral Tablet
-
Kahramanmaraş, TurkeyKahramanmaras Sutcuimam University Ophthalmology Department
Aug 10, 2018
Generalized Epilepsy Trial in Bhubaneswar (Melatonin 3 mg, Placebo)
Completed
- Generalized Epilepsy
- Melatonin 3 mg
- Placebo
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Sep 1, 2020
Postoperative Pain, Delirium, Confusion Trial in New York (Melatonin, Placebo)
Completed
- Postoperative Pain
- +3 more
- Melatonin
- Placebo
-
New York, New YorkHospital for Special Surgery
Apr 19, 2022
Schizophrenia, Schizoaffective Disorder, Delusional Disorder Trial in Mannheim (agomelatine)
Completed
- Schizophrenia
- +2 more
- agomelatine
-
Mannheim, Baden-Württemberg, GermanyCentral Institute of Mental Health
Mar 7, 2018